Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: A Descriptive Analysis

This report contains the estimates of utilization of hydrochlorothiazide (HCTZ)-containing diuretics, non HCTZ-containing diuretics, and antihypertensives in the Sentinel Distributed Database (SDD) to understand the impact of labeling updates that were made on August 8, 2020. 

The study period includes data from January 1, 2017 to June 30, 2022. We distributed this request to five Sentinel Data Partners on December 12, 2022.